Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Instil Bio, Inc. (TIL) had Consolidated Net Income/Loss of $-4.20M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.20M |
|
-- |
|
-- |
|
$7.01M |
|
$-7.01M |
|
$2.81M |
|
$-4.20M |
|
$-4.20M |
|
$-4.20M |
|
$-4.20M |
|
|
Consolidated Net Income/Loss |
$-4.20M |
$-4.20M |
|
$-7.01M |
|
$-7.00M |
|
6.78M |
|
6.78M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$188.30M |
|
$0.11M |
|
$12.13M |
|
$200.43M |
|
$4.72M |
|
$85.00M |
|
$85.01M |
|
$89.73M |
|
$110.70M |
|
$110.70M |
|
$110.70M |
|
6.78M |
|
| Cash Flow Statement Financials | |
$-1.34M |
|
$-0.32M |
|
$0.00M |
|
$6.80M |
|
$5.14M |
|
$-1.66M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
39.87 |
|
-- |
|
-- |
|
0.43 |
|
0.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.80% |
|
-3.80% |
|
-2.10% |
|
-2.15% |
|
$16.32 |
|
$-0.20 |
|
$-0.20 |
|